Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 2129

1.

Carrying the T Allele of the SNP rs574344, an eQTL of GSTM1, Contributes to Longevity in the Han Chinese Population.

Zhang Y, Zhang S, Yan D, Pan H, Liu B, Li T, Wang X, Cai W, Wang B.

Genet Test Mol Biomarkers. 2019 Jan;23(1):12-15. doi: 10.1089/gtmb.2018.0178. Epub 2018 Dec 27.

PMID:
30589570
2.

Complex Haplotypes of GSTM1 Gene Deletions Harbor Signatures of a Selective Sweep in East Asian Populations.

Saitou M, Satta Y, Gokcumen O.

G3 (Bethesda). 2018 Aug 30;8(9):2953-2966. doi: 10.1534/g3.118.200462.

3.

Glutathione S-transferase (GST) polymorphism could be an early marker in the development of polycystic ovary syndrome (PCOS) - an insight from non-obese and non-insulin resistant adolescents.

Savić-Radojević A, Mažibrada I, Djukić T, Stanković ZB, Plješa-Ercegovac M, Sedlecky K, Bjekić-Macut J, Simić T, Mastorakos G, Macut D.

Endokrynol Pol. 2018;69(4):366-374. doi: 10.5603/EP.a2018.0034. Epub 2018 Jun 28.

4.

The influence of polymorphic GSTM1 gene on the increased susceptibility of non-viral hepatic cirrhosis: evidence from observational studies.

Gu Y, Zhao J, Ao L, Ma J, Bao K, Liu M, Huang W.

Eur J Med Res. 2018 Jun 19;23(1):34. doi: 10.1186/s40001-018-0331-z. Review.

5.

A systematic review and meta-analyses of the relationship between glutathione S-transferase gene polymorphisms and renal cell carcinoma susceptibility.

Zhong Z, Li H, Zhong H, Zhou T, Xie W, Lin Z.

BMC Med Genet. 2018 Jun 8;19(1):98. doi: 10.1186/s12881-018-0620-y.

7.

Association of glutathione S-transferase M1 polymorphisms in the colorectal cancer risk: A meta-analysis.

Huang M, Zeng Y, Zhao F, Huang Y.

J Cancer Res Ther. 2018 Jan;14(1):176-183. doi: 10.4103/jcrt.JCRT_446_16.

8.

A sequence polymorphism on 8q24 is associated with survival in hepatocellular carcinoma patients who received radiation therapy.

Zhao XM, Xiang ZL, Chen YX, Yang P, Hu Y, Zeng ZC.

Sci Rep. 2018 Feb 2;8(1):2264. doi: 10.1038/s41598-018-20700-x.

9.

Human glutathione s-transferase enzyme gene variations and risk of multiple sclerosis in Iranian population cohort.

Parchami Barjui S, Reiisi S, Bayati A.

Mult Scler Relat Disord. 2017 Oct;17:41-46. doi: 10.1016/j.msard.2017.06.016. Epub 2017 Jun 28.

PMID:
29055472
10.

The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Tin A, Scharpf R, Estrella MM, Yu B, Grove ML, Chang PP, Matsushita K, Köttgen A, Arking DE, Boerwinkle E, Le TH, Coresh J, Grams ME.

J Am Soc Nephrol. 2017 Nov;28(11):3345-3352. doi: 10.1681/ASN.2017030228. Epub 2017 Jul 18.

11.

Measurement of absolute copy number variation of Glutathione S-Transferase M1 gene by digital droplet PCR and association analysis in Tunisian Rheumatoid Arthritis population.

Achour Y, Ben Kilani MS, Ben Hamad M, Marzouk S, Mahfoudh N, Bahloul Z, Keskes L, Petit-Teixeira E, Maalej A.

J Clin Lab Anal. 2018 Mar;32(3). doi: 10.1002/jcla.22300. Epub 2017 Jul 13.

PMID:
28703442
12.

Role of Donors and Recipients' Glutathione S-Transferase Gene Polymorphisms in Association of Oxidative Stress With Delayed Graft Function in Kidney Allograft Recipients.

Azmandian J, Mandegary A, Pootari M, Nematolahi MH, Ebadzadeh MR, Habibzadeh SD, Dehghani-Firouzabadi MH, Etminan A, Fazeli F, Mousavi M.

Iran J Kidney Dis. 2017 May;11(3):241-248.

13.

GSTM1 polymorphism in patients with clinical manifestations of atherosclerosis.

Rodrigues DA, Martins JV, E Silva KS, Costa IR, Lagares MH, Campedelli FL, Barbosa AM, de Morais MP, Moura KK.

Genet Mol Res. 2017 Mar 15;16(1). doi: 10.4238/gmr16019101.

PMID:
28362975
14.

Tracing biomarker of PAH-exposure and susceptibility factor (GSTM-polymorphism) among cancer patients in Pakistan.

Abdur Rehman MY, Kamal A, Taqi MM, Malik RN.

Chemosphere. 2017 Jul;178:384-390. doi: 10.1016/j.chemosphere.2017.03.017. Epub 2017 Mar 7.

PMID:
28340461
15.

GENOTYPE ASSOCIATION GSTM1 NULL AND GASTRIC CANCER: EVIDENCE-BASED META-ANALYSIS.

Ribeiro RX, Nascimento CILL, Silva AMTC.

Arq Gastroenterol. 2017 Apr-Jun;54(2):101-108. doi: 10.1590/S0004-2803.201700000-14. Epub 2017 Mar 16.

16.

GSTM1 genotype is an independent prognostic factor in clear cell renal cell carcinoma.

Coric VM, Simic TP, Pekmezovic TD, Basta-Jovanovic GM, Savic-Radojevic AR, Radojevic-Skodric SM, Matic MG, Suvakov SR, Dragicevic DP, Radic TM, Dzamic ZM, Pljesa-Ercegovac MS.

Urol Oncol. 2017 Jun;35(6):409-417. doi: 10.1016/j.urolonc.2017.02.005. Epub 2017 Mar 9.

PMID:
28284893
17.

Glutathione S-transferase M1 Polymorphism and Breast Cancer Risk: a Meta-Analysis in the Chinese Population.

Xue CX, He XM, Zou DH.

Clin Lab. 2016 Nov 1;62(11):2277-2284. doi: 10.7754/Clin.Lab.2016.160333. Review.

PMID:
28164656
18.

The glutathione transferase Mu null genotype leads to lower 6-MMPR levels in patients treated with azathioprine but not with mercaptopurine.

Broekman MMTJ, Wong DR, Wanten GJA, Roelofs HM, van Marrewijk CJ, Klungel OH, Verbeek ALM, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, Coenen MJH, de Jong DJ.

Pharmacogenomics J. 2018 Jan;18(1):160-166. doi: 10.1038/tpj.2016.87. Epub 2017 Jan 3.

PMID:
28045129
19.

GSTM1 null polymorphism prevalence in tobacco users, oral leukoplakia and oral squamous cell carcinoma patients in South Indian population: A polymerase chain reaction study.

Tanwar R, Iyengar AR, Nagesh KS, Patil S, Subhash BV.

Indian J Dent Res. 2016 Jul-Aug;27(4):353-358. doi: 10.4103/0970-9290.191881.

20.

A new method for identifying causal genes of schizophrenia and anti-tuberculosis drug-induced hepatotoxicity.

Huang T, Liu CL, Li LL, Cai MH, Chen WZ, Xu YF, O'Reilly PF, Cai L, He L.

Sci Rep. 2016 Sep 1;6:32571. doi: 10.1038/srep32571.

Supplemental Content

Support Center